Studies have shown that when tumour develops, the expression of TβRII by breast cancer cells is diminished, which results in reduced response of tumour cells to TGF-β1 signalling and increased secretion of the ligand (Akhurst and Balmain, 1999; Reiss, 1999). This evidence concerns the gene TGFB1 and breast cancer.